loading page

Antiarrhythmic Drug Initiation: How and Where
  • +1
  • Joshua Newman,
  • Adam Strickberger,
  • Jenna Spears,
  • Peter Kowey
Joshua Newman
Lankenau Medical Center Cancer Center

Corresponding Author:newmanj@mlhs.org

Author Profile
Adam Strickberger
AltaThera Pharmaceuticals LLC
Author Profile
Jenna Spears
Lankenau Medical Center Cancer Center
Author Profile
Peter Kowey
Lankenau Medical Center Cancer Center
Author Profile

Abstract

“‘latex Atrial fibrillation (AF) is common and occurs in approximately 8% of adults over sixty-five years of age in the United States.[1](#ref-0001) Prevention of AF, with maintenance of healthy weight, treatment of sleep apnea, and regular exercise are key strategies. As prevention is often inadequate, the role of antiarrhythmic drugs (AADs) is paramount. The risk of adverse events during initiation is greatest in the first 24 hours, and is approximately 10-15%, but AADs can still be used safely.[2](#ref-0002) Herein, we describe the various categories in a practical guide to initiation in order to make clinicians more comfortable with starting and maintaining antiarrhythmic therapy in both the inpatient and outpatient setting. The central illustration summarizes the article.
13 Nov 2024Submitted to Journal of Cardiovascular Electrophysiology
14 Nov 2024Submission Checks Completed
14 Nov 2024Assigned to Editor
14 Nov 2024Review(s) Completed, Editorial Evaluation Pending
18 Nov 2024Editorial Decision: Revise Minor
05 Dec 20241st Revision Received
06 Dec 2024Submission Checks Completed
06 Dec 2024Assigned to Editor
06 Dec 2024Review(s) Completed, Editorial Evaluation Pending
10 Dec 2024Reviewer(s) Assigned
20 Dec 2024Editorial Decision: Revise Minor